The PFAS Restriction Proposal is official. What this means for your organization
For several years, regulatory frameworks have indicated that PFAS restrictions would reach Europe. Now the European Chemicals Agency has confirmed the details: 14 sectors are included in the upcoming restriction proposal, and the implementation timeline requires immediate attention. Official document can be found here.
Your organization likely operates within one of these affected sectors. Metal plating and manufacture of metal products. Applications of fluorinated gases. Renewable energy. Batteries. Medical devices. Textiles. Whether your organization manufactures products, sources materials, or distributes goods—PFAS is present in your supply chain.
The regulatory timeline is compressed. December 2025 brings final sector agreements. March 2026 introduces the SEAC draft opinion. Post-March 2026 launches the formal consultation period. Organizations must have comprehensive data and strategic responses in place before these dates arrive.
Understanding your regulatory requirements
The European Chemicals Agency has not established uniform requirements across all sectors. Rather, each of the 14 sectors faces sector-specific, detailed evaluations. Your organization must document exactly where PFAS appears in your operations—which products, which materials, which processes, which suppliers.
This analysis requires more than basic identification. It demands systematic mapping, comprehensive documentation, informed decision-making regarding alternatives, supply chain assessment, and structured data management across your organization.
Many organizations currently lack the systems and data infrastructure to meet these requirements within the available timeline.
The Timeline Requires Immediate Action
Between now and March 2026, organizations have approximately four months to develop comprehensive understanding of their PFAS exposure and establish their compliance strategy. This timeline is limited but sufficient for organizations that begin their assessment immediately.
Delay significantly reduces the time available for thorough analysis, alternative evaluation, supplier engagement, and supply chain adjustment.
How CDX supports your PFAS compliance strategy
Compliance Data eXchange (CDX) provides a centralized platform designed for organizations to map, manage, and document their PFAS footprint across their supply chain. CDX replaces fragmented data collection methods with integrated systems:
- Supply Chain Mapping — Establish a clear, documented inventory of where PFAS appears across your products, materials, and processes.
- Centralized Data Management — Consolidate supplier information, material specifications, and chemical use data in one structured system rather than managing multiple documents and spreadsheets.
- Compliance Documentation — Organize and prepare verified data that responds directly to regulatory requirements and consultation questions expected from the European Chemicals Agency.
- Supply Chain Transparency — Exchange compliance information securely with suppliers and business partners, establishing clear accountability and reducing supply chain risk.
- Strategic Decision Support — Access organized data that enables informed analysis of alternative materials, process modifications, and supply chain adjustments.
Begin Your PFAS assessment today
Do not wait until the March 2026 consultation period to assess your organization's PFAS requirements. Initiate your supply chain mapping now. Develop a complete understanding of your PFAS exposure. Establish your compliance pathway.
Request a demonstration of CDX. Understand the platform capabilities that support your compliance requirements. Establish your timeline for readiness.
The PFAS restriction proposal represents a significant regulatory development. Organizations that are fully prepared will manage the transition effectively. Organizations that lack preparation will experience material disruption.
Which approach will your organization take?
Stay informed. Get the latest regulatory updates, compliance insights, and CDX news delivered to your inbox.
Subscribe to our Newsletter